Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries

The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited

(2017) Donald H. Taylor et al.   JOURNAL OF ALZHEIMERS DISEASE

Pharmacological Treatment of Alzheimer's Disease: Effect of Race and Demographic Variables

(2017) Santiago Hernandez et al.   JOURNAL OF ALZHEIMERS DISEASE

2015 Alzheimer's disease facts and figures

(2015)   Alzheimers & Dementia

Continuous treatment with antidementia drugs in Germany 2003–2013: a retrospective database analysis

(2015) Jens Bohlken et al.   INTERNATIONAL PSYCHOGERIATRICS

A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe

(2014) Virginie Gardette et al.   CNS DRUGS

Medication Adherence in Patients With Dementia

(2013) Bernhard Haider et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

(2013) Parminder Raina et al.   ANNALS OF INTERNAL MEDICINE

Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians

(2013) Amir Qaseem   ANNALS OF INTERNAL MEDICINE

Has Medicare Part D Reduced Racial/Ethnic Disparities in Prescription Drug Use and Spending?

(2013) Elham Mahmoudi et al.   HEALTH SERVICES RESEARCH

The impact of Medicare prescription drug coverage on the use of antidementia drugs

(2013) Nicole R Fowler et al.   BMC Geriatrics

Racial and Ethnic Disparities in Alzheimer's Disease Pharmacotherapy Exposure: An Analysis Across Four State Medicaid Populations

(2012) Adrienne M. Gilligan et al.   American Journal Geriatric Pharmacotherapy

Cross-cultural differences in dementia: the Sociocultural Health Belief Model

(2012) Philip Sayegh et al.   INTERNATIONAL PSYCHOGERIATRICS

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

(2012) Robert Howard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimating the Economic Burden of Racial Health Inequalities in the United States

(2011) Thomas A. LaVeist et al.   INTERNATIONAL JOURNAL OF HEALTH SERVICES

Racial and Ethnic Disparities in the Treatment of Dementia Among Medicare Beneficiaries

(2011) I. H. Zuckerman et al.   JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES

Effect of Patient Selection Method on Provider Group Performance Estimates

(2011) Carolyn T. Thorpe et al.   MEDICAL CARE

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

(2010) John T O’Brien et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease

(2010) Joseph E. Amuah et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Racial/Ethnic Disparities in Medication Use Among Veterans with Hypertension and Dementia: A National Cohort Study

(2009) Ivy Poon et al.   ANNALS OF PHARMACOTHERAPY

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

(2009) Susan D Rountree et al.   Alzheimers Research & Therapy

Factors Affecting Usage Patterns of Memantine in Alzheimer Disease

(2008) Alan J. Lerner et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Alzheimer's and Non-Alzheimer's Dementia: A Critical Review of Pharmacological and Nonpharmacological Strategies

(2008) Sahoo Saddichha et al.   American Journal of Alzheimers Disease and Other Dementias

Racial and Ethnic Disparities in the VA Health Care System: A Systematic Review

(2008) Somnath Saha et al.   JOURNAL OF GENERAL INTERNAL MEDICINE